Contribution of treatment acceptability to acceptance of randomization: an exploration

Souraya Sidani, Mary Fox, Dana Epstein

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Rationale, aims and objectives: Randomization to treatment is viewed unfavourably by many trial participants. There is limited research that investigated factors contributing to acceptance of randomization. This study explored the influence of participants' socio-demographic and clinical characteristics, and their perceived acceptability of the treatments on their acceptance of randomization (i.e. willingness to be randomized) in a clinical trial. Methods: Persons with insomnia (n = 383) were asked about their acceptance of randomization before and after they rated the acceptability of behavioural therapies for managing insomnia (sleep education and hygiene booklet, stimulus control therapy and sleep restriction therapy). Socio-demographic and clinical characteristics, and treatment acceptability, were measured with established instruments. Logistic regression was applied to explore the association between participants' characteristics and treatment acceptability, and reported acceptance of randomization. Results: Prior to rating treatments' acceptability, 54.6% of participants were willing to be randomized; socio-demographic (age and ethnicity) and clinical (severity of insomnia's impact, state anxiety, depression, vitality and mental and social functions) contributed to acceptance of randomization. After rating the treatments' acceptability, 87.8% of participants were unwilling to be randomized; age, severity of insomnia's impact and acceptability of behavioural therapy were significantly associated with acceptance of randomization. Conclusions: The study findings indicated that participants are likely to express unwillingness to be randomized once they receive treatment information and rate the acceptability of treatments. The reported non-acceptance may influence participants' behaviour (e.g. withdrawal, non-adherence) during the trial, suggesting the need to explore alternative designs for intervention evaluation.

Original languageEnglish (US)
Pages (from-to)14-20
Number of pages7
JournalJournal of Evaluation in Clinical Practice
Volume23
Issue number1
DOIs
StatePublished - Feb 1 2017
Externally publishedYes

Fingerprint

Random Allocation
Sleep Initiation and Maintenance Disorders
Therapeutics
Demography
Pamphlets
Sleep
Anxiety
Logistic Models
Clinical Trials
Depression
Education

Keywords

  • acceptance of randomization
  • behavioural therapy
  • insomnia
  • intervention research
  • treatment acceptability
  • willingness to be randomized

ASJC Scopus subject areas

  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

Contribution of treatment acceptability to acceptance of randomization : an exploration. / Sidani, Souraya; Fox, Mary; Epstein, Dana.

In: Journal of Evaluation in Clinical Practice, Vol. 23, No. 1, 01.02.2017, p. 14-20.

Research output: Contribution to journalArticle

@article{99bf9066dcd243f0b7997825d790ccb5,
title = "Contribution of treatment acceptability to acceptance of randomization: an exploration",
abstract = "Rationale, aims and objectives: Randomization to treatment is viewed unfavourably by many trial participants. There is limited research that investigated factors contributing to acceptance of randomization. This study explored the influence of participants' socio-demographic and clinical characteristics, and their perceived acceptability of the treatments on their acceptance of randomization (i.e. willingness to be randomized) in a clinical trial. Methods: Persons with insomnia (n = 383) were asked about their acceptance of randomization before and after they rated the acceptability of behavioural therapies for managing insomnia (sleep education and hygiene booklet, stimulus control therapy and sleep restriction therapy). Socio-demographic and clinical characteristics, and treatment acceptability, were measured with established instruments. Logistic regression was applied to explore the association between participants' characteristics and treatment acceptability, and reported acceptance of randomization. Results: Prior to rating treatments' acceptability, 54.6{\%} of participants were willing to be randomized; socio-demographic (age and ethnicity) and clinical (severity of insomnia's impact, state anxiety, depression, vitality and mental and social functions) contributed to acceptance of randomization. After rating the treatments' acceptability, 87.8{\%} of participants were unwilling to be randomized; age, severity of insomnia's impact and acceptability of behavioural therapy were significantly associated with acceptance of randomization. Conclusions: The study findings indicated that participants are likely to express unwillingness to be randomized once they receive treatment information and rate the acceptability of treatments. The reported non-acceptance may influence participants' behaviour (e.g. withdrawal, non-adherence) during the trial, suggesting the need to explore alternative designs for intervention evaluation.",
keywords = "acceptance of randomization, behavioural therapy, insomnia, intervention research, treatment acceptability, willingness to be randomized",
author = "Souraya Sidani and Mary Fox and Dana Epstein",
year = "2017",
month = "2",
day = "1",
doi = "10.1111/jep.12423",
language = "English (US)",
volume = "23",
pages = "14--20",
journal = "Journal of Evaluation in Clinical Practice",
issn = "1356-1294",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Contribution of treatment acceptability to acceptance of randomization

T2 - an exploration

AU - Sidani, Souraya

AU - Fox, Mary

AU - Epstein, Dana

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Rationale, aims and objectives: Randomization to treatment is viewed unfavourably by many trial participants. There is limited research that investigated factors contributing to acceptance of randomization. This study explored the influence of participants' socio-demographic and clinical characteristics, and their perceived acceptability of the treatments on their acceptance of randomization (i.e. willingness to be randomized) in a clinical trial. Methods: Persons with insomnia (n = 383) were asked about their acceptance of randomization before and after they rated the acceptability of behavioural therapies for managing insomnia (sleep education and hygiene booklet, stimulus control therapy and sleep restriction therapy). Socio-demographic and clinical characteristics, and treatment acceptability, were measured with established instruments. Logistic regression was applied to explore the association between participants' characteristics and treatment acceptability, and reported acceptance of randomization. Results: Prior to rating treatments' acceptability, 54.6% of participants were willing to be randomized; socio-demographic (age and ethnicity) and clinical (severity of insomnia's impact, state anxiety, depression, vitality and mental and social functions) contributed to acceptance of randomization. After rating the treatments' acceptability, 87.8% of participants were unwilling to be randomized; age, severity of insomnia's impact and acceptability of behavioural therapy were significantly associated with acceptance of randomization. Conclusions: The study findings indicated that participants are likely to express unwillingness to be randomized once they receive treatment information and rate the acceptability of treatments. The reported non-acceptance may influence participants' behaviour (e.g. withdrawal, non-adherence) during the trial, suggesting the need to explore alternative designs for intervention evaluation.

AB - Rationale, aims and objectives: Randomization to treatment is viewed unfavourably by many trial participants. There is limited research that investigated factors contributing to acceptance of randomization. This study explored the influence of participants' socio-demographic and clinical characteristics, and their perceived acceptability of the treatments on their acceptance of randomization (i.e. willingness to be randomized) in a clinical trial. Methods: Persons with insomnia (n = 383) were asked about their acceptance of randomization before and after they rated the acceptability of behavioural therapies for managing insomnia (sleep education and hygiene booklet, stimulus control therapy and sleep restriction therapy). Socio-demographic and clinical characteristics, and treatment acceptability, were measured with established instruments. Logistic regression was applied to explore the association between participants' characteristics and treatment acceptability, and reported acceptance of randomization. Results: Prior to rating treatments' acceptability, 54.6% of participants were willing to be randomized; socio-demographic (age and ethnicity) and clinical (severity of insomnia's impact, state anxiety, depression, vitality and mental and social functions) contributed to acceptance of randomization. After rating the treatments' acceptability, 87.8% of participants were unwilling to be randomized; age, severity of insomnia's impact and acceptability of behavioural therapy were significantly associated with acceptance of randomization. Conclusions: The study findings indicated that participants are likely to express unwillingness to be randomized once they receive treatment information and rate the acceptability of treatments. The reported non-acceptance may influence participants' behaviour (e.g. withdrawal, non-adherence) during the trial, suggesting the need to explore alternative designs for intervention evaluation.

KW - acceptance of randomization

KW - behavioural therapy

KW - insomnia

KW - intervention research

KW - treatment acceptability

KW - willingness to be randomized

UR - http://www.scopus.com/inward/record.url?scp=84937700310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937700310&partnerID=8YFLogxK

U2 - 10.1111/jep.12423

DO - 10.1111/jep.12423

M3 - Article

C2 - 26201452

AN - SCOPUS:84937700310

VL - 23

SP - 14

EP - 20

JO - Journal of Evaluation in Clinical Practice

JF - Journal of Evaluation in Clinical Practice

SN - 1356-1294

IS - 1

ER -